drugset / Trial / NCT05252598
Mood and Cognitive Effects of Psilocybin in Healthy Participants
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This study is seeking to find the optimal microdose or low dose of psilocybin (magic mushrooms) that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects.
Timeline
- Start
- 2023-01
- Primary completion
- 2023-08
- Completion
- 2023-12
Outcome
Outcome not reported
Stopped: “The sponsor no longer wishes to pursue the methods outlined in the protocol.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 1 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 2 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 5 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 8 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 10 mg | Oral |